Aptorum Group Ltd Class A (APM)
Official siteBIOTECHNOLOGY
Last updated: Jul 17, 2026 at 5:00 PM ET
Aptorum Group Ltd Class A (APM) Financials: Revenue, Profit and Cash Flow
Aptorum Group Ltd Class A reported revenue of $0 for the fiscal year ended Dec 31, 2025. That year, net income was -$1.36M, operating cash flow was -$1.84M and free cash flow was -$1.84M. The quarter ended Mar 31, 2026 had net income of -$921.49K.
Revenue and Margins
The company reported no revenue in the fiscal year ended Dec 2025, with an operating loss of $1.82M.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $0 | N/A | N/A | N/A | N/A |
| Dec 2024 | $0 | -100.0% | N/A | N/A | N/A |
| Dec 2023 | $431.38K | -66.7% | 2.4% | -2457.5% | -654.9% |
| Dec 2022 | $1.30M | -16.0% | 6.2% | -1351.0% | -756.2% |
| Dec 2021 | $1.54M | +69.2% | 5.3% | -1245.6% | -1624.4% |
| Dec 2020 | $911.51K | +70.3% | -11.4% | -2182.6% | 775.3% |
| Dec 2019 | $535.17K | +39.6% | -48.4% | -3400.4% | -3491.8% |
| Dec 2018 | $383.45K | N/A | 17.1% | -2693.4% | -3868.0% |
| Dec 2017 | $0 | N/A | N/A | N/A | N/A |
| Dec 2016 | $0 | N/A | N/A | N/A | N/A |
Income Statement
In the fiscal year ended Dec 2025, the net loss narrowed from the year before. In the quarter ended Mar 2026, the net loss narrowed from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $431.38K | $1.30M | $1.54M | $911.51K | $535.17K | $383.45K | $0 | $0 |
| Cost of revenue | $0 | $255.05K | $420.81K | $1.22M | $1.46M | $1.01M | $794.54K | $318.01K | $58.90K | $0 |
| Gross profit | $0 | -$255.00K | $10.57K | $80.06K | $81.85K | -$104.00K | -$259.00K | $65.44K | -$58.90K | $0 |
| Research and development | $352.88K | $1.94M | $5.20M | $9.22M | $10.87M | $11.59M | $6.94M | $3.10M | $2.50M | $2.56M |
| Operating income | -$1.82M | -$3.80M | -$10.60M | -$17.51M | -$19.21M | -$19.89M | -$18.20M | -$10.33M | -$5.69M | -$878.23K |
| Net income | -$1.36M | -$4.27M | -$2.83M | -$9.80M | -$25.05M | $7.07M | -$18.69M | -$14.83M | -$2.55M | -$2.13M |
| EBITDA | -$1.82M | -$3.76M | -$9.48M | -$10.32M | N/A | $6.50M | -$15.12M | -$9.99M | -$2.50M | N/A |
Quarterly
| Line item | Mar 2026 | Dec 2025 | Sep 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Mar 2024 | Sep 2023 | Mar 2023 | Jun 2022 | Mar 2022 | Jun 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | N/A | $0 | $0 | N/A | $0 | $0 | N/A | $431.38K | $768.43K | $527.46K | -$1.25M | $637.78K |
| Gross profit | N/A | N/A | N/A | N/A | N/A | -$255.00K | -$455.00K | -$665.00K | -$542.00K | -$585.00K | -$2.49M | -$589.00K |
| Operating income | -$1.41M | -$1.41M | -$402.77K | -$1.07M | $558.60K | -$2.87M | -$3.99M | -$6.54M | -$9.06M | -$8.45M | $25.68M | -$9.49M |
| Net income | -$921.49K | -$921.49K | -$441.78K | -$1.62M | -$919.90K | -$2.64M | $2.66M | -$5.49M | -$7.91M | -$1.89M | -$2.22M | -$16.08M |
Balance Sheet
As of Dec 2025, cash and equivalents exceeded short-term debt of $3.44M by $9.96K.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $18.69M | $16.13M | $20.64M | $20.87M | $21.91M | $44.23M | $23.95M | $45.07M | $31.56M | $25.38M |
| Current assets | $3.59M | $959.55K | $2.48M | $7.07M | $12.69M | $33.66M | $8.03M | $28.72M | $20.28M | $402.11K |
| Cash and equivalents | $3.45M | $874.24K | $2.01M | $1.88M | $8.13M | $3.50M | $5.19M | $12.01M | $16.25M | $301.64K |
| Total liabilities | $4.90M | $4.35M | $5.26M | $13.03M | $4.40M | $6.08M | $9.10M | $12.33M | $1.33M | $269.84K |
| Short-term debt | $3.44M | $3.34M | $329.64K | $6.32M | $398.02K | $1.11M | $46.55K | $10.15M | $480.00K | N/A |
| Long-term debt | N/A | N/A | $3.06M | $500.00K | N/A | $2.01M | $6.33M | N/A | N/A | N/A |
| Shareholder equity | $23.12M | $21.13M | $24.85M | $15.71M | $23.61M | $41.83M | $16.36M | $33.11M | $30.24M | $25.11M |
Quarterly
| Line item | Mar 2026 | Dec 2025 | Sep 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $18.69M | $18.69M | $18.10M | $16.13M | $16.13M | $17.70M | $17.70M | $20.64M | $20.64M | $14.41M | $14.41M | $20.87M |
| Total liabilities | $4.90M | $4.90M | $4.34M | $4.35M | $4.35M | $4.53M | $4.53M | $5.26M | $5.26M | $1.63M | $1.63M | $13.03M |
| Cash and equivalents | $3.45M | $3.45M | $2.76M | $874.24K | $874.24K | $783.09K | $783.09K | $2.01M | $2.01M | $340.31K | $340.31K | $1.88M |
| Shareholder equity | $23.12M | $23.12M | $23.13M | $21.13M | $21.13M | $22.65M | $22.65M | $24.85M | $24.85M | $21.84M | $21.84M | $15.71M |
Cash Flow
Operating cash flow was negative in the fiscal year ended Dec 2025.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$1.84M | -$1.19M | -$7.72M | -$12.32M | -$14.65M | -$15.93M | -$13.38M | -$10.04M | -$5.78M | -$2.76M |
| Capital expenditures | $2 | $1 | $3.01K | $186.92K | $137.78K | $161.31K | $1.11M | $6.06M | $3.06M | $2.09M |
| Free cash flow | -$1.84M | -$1.19M | -$7.73M | -$12.51M | -$14.79M | -$16.09M | -$14.49M | -$16.10M | -$8.84M | -$4.85M |
| Dividends paid | N/A | N/A | N/A | N/A | N/A | $755.51K | N/A | N/A | N/A | $51.88K |
| Investing cash flow | N/A | $58.62K | $624.77K | $2.44M | $16.51M | $1.84M | -$108.06K | -$6.06M | $12.80M | $12.80M |
| Financing cash flow | $4.41M | $1.43K | $4.09M | $6.63M | $2.78M | $12.42M | -$7.32M | $25.48M | $9.08M | $386.42K |
Quarterly
| Line item | Dec 2025 | Sep 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Mar 2024 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$535.72K | -$484.28K | $89.73K | $119.65K | -$1.28M | -$1.54M | -$6.24M | N/A | -$5.46M | $3.34B |
| Capital expenditures | $0 | $0 | $2 | $0 | $3 | $42 | $2.98K | $0 | $36.36K | $4.81B |
| Free cash flow | -$535.72K | -$484.28K | $89.73K | $119.65K | -$1.28M | -$1.54M | -$6.24M | N/A | -$5.50M | -$1.47B |
Frequently Asked Questions About APM
What is Aptorum Group Ltd Class A's annual revenue?
Aptorum Group Ltd Class A reported revenue of $0 for the fiscal year ended Dec 31, 2025.
Is Aptorum Group Ltd Class A profitable?
No. Aptorum Group Ltd Class A reported net income of -$1.36M for the fiscal year ended Dec 31, 2025.
How much free cash flow does APM generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of -$1.84M minus capital expenditures of $2 produced free cash flow of -$1.84M.
How much debt does Aptorum Group Ltd Class A have?
The balance sheet dated Dec 31, 2025 reported short-term debt of $3.44M and cash and equivalents of $3.45M.
APM pages: Overview, Financials